Considering that metastases are responsible for 90% of cancer deaths, we propose the following new hypothesis: the worse prognosis of patients with tumors with high levels of endoglin is not due to increased tumor size; instead, the overexpression of endoglin maintains the activation of the endothelium and increases the risk of metastases. This evidence concerns the gene ENG and neoplasm.